Image

Coronary Bifurcations With Ischaemia and Flow Assessment

Coronary Bifurcations With Ischaemia and Flow Assessment

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The coronary arteries are blood vessels that provide oxygen rich blood to the muscle of the heart. If these vessels become narrowed or blocked, this can lead to chest pain (called angina) or heart attacks. Narrowings are usually treated using metal scaffolds called drug eluting stents. However, in one in five cases where the narrowing occurs at a branching point, treating it with stents is more challenging and can cause complications. A possible alternative treatment is using a special type of balloon called a drug-coated balloon. This balloon is inflated in the blood vessel and releases medicine to help widen the blood vessel and the procedure is completed without leaving any metallic scaffold behind.

This study aims to compare drug coated balloons with drug eluting stents to see which treatment works better for narrowing that occurs at branching points. We will used advanced imaging techniques to create computer models of blood flow in the vessels, and we will follow up with patients over tie to see how well the treatments work.

Eligibility

Inclusion Criteria:

  • Age 18 or over
  • Any bifurcation lesion amenable to a provisional main vessel treatment strategy
  • A main vessel diameter of 2.5mm or more and side branch diameter of >2mm
  • Any patient with stable angina, silent ischaemia, unstable angina or NSTEMI
  • Able to give informed consent

Exclusion Criteria:

  • Cardiogenic shock
  • LVEF <30%
  • STEMI (as unable to give informed consent)
  • eGFR <30
  • Severe asthma contraindicating use of adenosine
  • High degree AV block on 12 lead ECG precluding the use of adenosine
  • Pregnancy
  • Inability to consent
  • Left main stem coronary bifurcation lesions

Study details
    Coronary Bifurcation Lesions

NCT06971718

University of East Anglia

20 May 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.